159 related articles for article (PubMed ID: 516774)
1. Clinical studies with gastric inhibitory polypeptide.
Brown JC; Otte S
World J Surg; 1979 Sep; 3(5):553-8. PubMed ID: 516774
[TBL] [Abstract][Full Text] [Related]
2. Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution.
Ebert R; Creutzfeldt W
Diabetologia; 1980 Sep; 19(3):198-204. PubMed ID: 6997121
[TBL] [Abstract][Full Text] [Related]
3. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance.
Ebert R; Frerichs H; Creutzfeldt W
Eur J Clin Invest; 1979 Apr; 9(2 Pt 1):129-35. PubMed ID: 111943
[TBL] [Abstract][Full Text] [Related]
4. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus.
Elahi D; Andersen DK; Muller DC; Tobin JD; Brown JC; Andres R
Diabetes; 1984 Oct; 33(10):950-7. PubMed ID: 6383904
[TBL] [Abstract][Full Text] [Related]
5. Response of gastric inhibitory polypeptide (GIP) to test meal in chronic pancreatitis--relationship to endocrine and exocrine insufficiency.
Ebert R; Creutzfeldt W; Brown JC; Frerichs H; Arnold R
Diabetologia; 1976 Dec; 12(6):609-12. PubMed ID: 1001849
[TBL] [Abstract][Full Text] [Related]
6. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
Verdonk CA; Rizza RA; Nelson RL; Go VL; Gerich JE; Service FJ
J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457
[TBL] [Abstract][Full Text] [Related]
7. Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus.
Crockett SE; Mazzaferri EL; Cataland S
Diabetes; 1976 Oct; 25(10):931-5. PubMed ID: 976601
[TBL] [Abstract][Full Text] [Related]
8. Gastric inhibitory polypeptide.
Ebert R; Creutzfeldt W
Clin Gastroenterol; 1980 Sep; 9(3):679-98. PubMed ID: 6107191
[TBL] [Abstract][Full Text] [Related]
9. Gastric inhibitory polypeptide in obesity and diabetes mellitus.
Service FJ; Rizza RA; Westland RE; Hall LD; Gerich JE; Go VL
J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812
[TBL] [Abstract][Full Text] [Related]
10. Glucose-dependent insulinotropic polypeptide augmentation of insulin. Physiology or pharmacology?
Sarson DL; Wood SM; Kansal PC; Bloom SR
Diabetes; 1984 Apr; 33(4):389-93. PubMed ID: 6368294
[TBL] [Abstract][Full Text] [Related]
11. The effect of glucose-dependent insulinotropic polypeptide infused at physiological concentrations on the release of insulin in man.
Sarson DL; Wood SM; Holder D; Bloom SR
Diabetologia; 1982 Jan; 22(1):33-6. PubMed ID: 7037506
[TBL] [Abstract][Full Text] [Related]
12. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man.
Falko JM; Crockett SE; Cataland S; O'Dorisio TM; Kramer W; Mazzaferri EL
Clin Endocrinol (Oxf); 1980 Dec; 13(6):587-93. PubMed ID: 7014042
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic alpha- and beta-cell responses to GIP infusion in normal man.
Elahi D; Andersen DK; Brown JC; Debas HT; Hershcopf RJ; Raizes GS; Tobin JD; Andres R
Am J Physiol; 1979 Aug; 237(2):E185-91. PubMed ID: 464094
[No Abstract] [Full Text] [Related]
14. Gastric inhibitory polypeptide (GIP) and insulin release in the obese Zucker rat.
Chan CB; Pederson RA; Buchan AM; Tubesing KB; Brown JC
Diabetes; 1984 Jun; 33(6):536-42. PubMed ID: 6373459
[TBL] [Abstract][Full Text] [Related]
15. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
Meier JJ; Gallwitz B; Askenas M; Vollmer K; Deacon CF; Holst JJ; Schmidt WE; Nauck MA
Diabetologia; 2005 Sep; 48(9):1872-81. PubMed ID: 16010522
[TBL] [Abstract][Full Text] [Related]
16. [Gastric inhibitory polypeptide (GIP) (author's transl].
Ebert R; Finke U
Z Gastroenterol; 1978 May; 16(5):311-6. PubMed ID: 654387
[TBL] [Abstract][Full Text] [Related]
17. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
[TBL] [Abstract][Full Text] [Related]
18. The role of endogenous gastric inhibitory polypeptide in the enteroinsular axis.
Takemura J; Seino Y; Yamamura T; Tsuda K; Seino S; Itoh N; Imura H
J Clin Endocrinol Metab; 1982 May; 54(5):909-13. PubMed ID: 7037822
[TBL] [Abstract][Full Text] [Related]
19. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
Nauck M; Schmidt WE; Ebert R; Strietzel J; Cantor P; Hoffmann G; Creutzfeldt W
J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324
[TBL] [Abstract][Full Text] [Related]
20. A supplementary infusion of glucose-dependent insulinotropic polypeptide (GIP) with a meal does not significantly improve the beta cell response or glucose tolerance in type 2 diabetes mellitus.
Jones IR; Owens DR; Vora J; Luzio SD; Hayes TM
Diabetes Res Clin Pract; 1989 Nov; 7(4):263-9. PubMed ID: 2693029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
